Gorkom, Britta Laros-van <br/><br/>
Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Dec 2020 
 - 17-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1607-8454 
<br/><br/><label>Standard No.: </label>10.1080/16078454.2019.1700329  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Coagulation--drug effects<br/>Factor VII Deficiency--blood<br/>Factor VIIa--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Recombinant Fusion Proteins--adverse effects<br/>Recombinant Proteins--adverse effects<br/>Serum Albumin, Human--adverse effects<br/>Treatment Outcome<br/>Young Adult